Fernando Caravaggio1,2, Jun Ku Chung1, Eric Plitman1, Isabelle Boileau1,2, Philip Gerretsen1,2, Julia Kim1, Yusuke Iwata1,2, Raihaan Patel3,4, M Mallar Chakravarty3,4,5, Gary Remington1,2, Ariel Graff-Guerrero1,2. 1. Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada. 2. Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, M5T 1R8, Canada. 3. Department of Biological & Biomedical Engineering, McGill University, Montreal, Quebec, H4H 1R3, Canada. 4. Cerebral Imaging Centre, Douglas Mental Health Institute, McGill University, Montreal, Quebec, H4H 1R3, Canada. 5. Department of Psychiatry, McGill University, Montreal, Quebec, H4H 1R3, Canada.
Abstract
BACKGROUND: Abnormalities in dopamine (DA) and brain morphology are observed in several neuropsychiatric disorders. However, it is not fully understood how these abnormalities may relate to one another. For such in vivo findings to be used as biomarkers for neuropsychiatric disease, it must be understood how variability in DA relates to brain structure under healthy conditions. We explored how the availability of striatal DA D2/3 receptors (D2/3 R) is related to the volume of subcortical brain structures in a sample of healthy humans. Differences in D2/3 R availability measured with an antagonist radiotracer ([11 C]-raclopride) versus an agonist radiotracer ([11 C]-(+)-PHNO) were examined. METHODS: Data from 62 subjects scanned with [11 C]-raclopride (mean age = 38.98 ± 14.45; 23 female) and 68 subjects scanned with [11 C]-(+)-PHNO (mean age = 38.54 ± 14.59; 25 female) were used. Subcortical volumes were extracted from T1-weighted images using the Multiple Automatically Generated Templates (MAGeT-Brain) algorithm. Partial correlations were used controlling for age, gender, and total brain volume. RESULTS: For [11 C]-(+)-PHNO, ventral caudate volumes were positively correlated with BPND in the dorsal caudate and globus pallidus (GP). Ventral striatum (VS) volumes were positively correlated with BPND in the VS. With [11 C]-raclopride, BPND in the VS was negatively correlated with subiculum volume of the hippocampus. Moreover, BPND in the GP was negatively correlated with the volume of the lateral posterior nucleus of the thalamus. CONCLUSION: Findings are purely exploratory and presented corrected and uncorrected for multiple comparisons. We hope they will help inform the interpretation of future PET studies where concurrent changes in D2/3 R and brain morphology are observed. Hum Brain Mapp 38:5519-5534, 2017.
BACKGROUND: Abnormalities in dopamine (DA) and brain morphology are observed in several neuropsychiatric disorders. However, it is not fully understood how these abnormalities may relate to one another. For such in vivo findings to be used as biomarkers for neuropsychiatric disease, it must be understood how variability in DA relates to brain structure under healthy conditions. We explored how the availability of striatal DA D2/3 receptors (D2/3 R) is related to the volume of subcortical brain structures in a sample of healthy humans. Differences in D2/3 R availability measured with an antagonist radiotracer ([11 C]-raclopride) versus an agonist radiotracer ([11 C]-(+)-PHNO) were examined. METHODS: Data from 62 subjects scanned with [11 C]-raclopride (mean age = 38.98 ± 14.45; 23 female) and 68 subjects scanned with [11 C]-(+)-PHNO (mean age = 38.54 ± 14.59; 25 female) were used. Subcortical volumes were extracted from T1-weighted images using the Multiple Automatically Generated Templates (MAGeT-Brain) algorithm. Partial correlations were used controlling for age, gender, and total brain volume. RESULTS: For [11 C]-(+)-PHNO, ventral caudate volumes were positively correlated with BPND in the dorsal caudate and globus pallidus (GP). Ventral striatum (VS) volumes were positively correlated with BPND in the VS. With [11 C]-raclopride, BPND in the VS was negatively correlated with subiculum volume of the hippocampus. Moreover, BPND in the GP was negatively correlated with the volume of the lateral posterior nucleus of the thalamus. CONCLUSION: Findings are purely exploratory and presented corrected and uncorrected for multiple comparisons. We hope they will help inform the interpretation of future PET studies where concurrent changes in D2/3 R and brain morphology are observed. Hum Brain Mapp 38:5519-5534, 2017.
Authors: M Mallar Chakravarty; Gilles Bertrand; Charles P Hodge; Abbas F Sadikot; D Louis Collins Journal: Neuroimage Date: 2006-01-09 Impact factor: 6.556
Authors: Doris E Payer; Arian Behzadi; Stephen J Kish; Sylvain Houle; Alan A Wilson; Pablo M Rusjan; Junchao Tong; Peter Selby; Tony P George; Tina McCluskey; Isabelle Boileau Journal: Neuropsychopharmacology Date: 2013-08-07 Impact factor: 7.853
Authors: Andri C Tziortzi; Graham E Searle; Sofia Tzimopoulou; Cristian Salinas; John D Beaver; Mark Jenkinson; Marc Laruelle; Eugenii A Rabiner; Roger N Gunn Journal: Neuroimage Date: 2010-06-30 Impact factor: 6.556
Authors: Mikaeel Valli; Sang Soo Cho; Mario Masellis; Robert Chen; Pablo Rusjan; Jinhee Kim; Yuko Koshimori; Alexander Mihaescu; Antonio P Strafella Journal: Mol Neurobiol Date: 2019-03-08 Impact factor: 5.590
Authors: Antoine Rogeau; Giovanna Nordio; Mattia Veronese; Kirsten Brown; Matthew M Nour; Martin Osugo; Sameer Jauhar; Oliver D Howes; Robert A McCutcheon Journal: Mol Psychiatry Date: 2022-05-11 Impact factor: 15.992
Authors: Natalie Remiszewski; James Edward Bryant; Saige E Rutherford; Andre F Marquand; Eric Nelson; Ibrahim Askar; Adrienne Carol Lahti; Nina Vanessa Kraguljac Journal: JAMA Psychiatry Date: 2022-09-28 Impact factor: 25.911
Authors: Fernando Caravaggio; Pontus Plavén-Sigray; Granville James Matheson; Eric Plitman; M Mallar Chakravarty; Jacqueline Borg; Ariel Graff-Guerrero; Simon Cervenka Journal: PLoS One Date: 2018-12-20 Impact factor: 3.240